Inbrija
Generic name: Levodopa Inhalation Capsules
Dosage form: inhalation capsule (42 mg)
Drug class:
Dopaminergic antiparkinsonism agents
Usage of Inbrija
Inbrija is an inhaled prescription medicine used to treat symptoms of Parkinson's disease that come back (OFF episodes) while you are taking another medicine called Carbidopa and Levodopa.
Inbrija is not to be used in place of any medicine you take daily for Parkinson's disease.
It is not known if Inbrija is safe or effective in children.
Inbrija side effects
Get emergency medical help if you have signs of an allergic reaction to Inbrija: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using Inbrija and call your doctor or seek emergency medical attention if you have a wheezing, chest tightness, or trouble breathing after inhaling this medicine.
Call your doctor at once if you have:
Some people using this medicine have fallen asleep during normal daytime activities such as working, talking, eating, or driving. This side effect has occurred up to 1 year after the start of treatment with Inbrija. Tell your doctor if you have any problems with daytime drowsiness.
Common Inbrija side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Inbrija
Do not use Inbrija if you have used an MAO inhibitor in the past 14 days. A dangerous drug interaction could occur. MAO inhibitors include isocarboxazid, linezolid, methylene blue injection, phenelzine, rasagiline, Selegiline, tranylcypromine, and others.
To make sure Inbrija is safe for you, tell your doctor if you have:
It is not known whether Inbrija inhalation will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.
Relate drugs
- Apokyn
- Apomorphine
- Apomorphine (Subcutaneous)
- Apomorphine (Sublingual)
- Azilect
- Comtan
- Carbidopa
- Carbidopa and levodopa
- Carbidopa and levodopa (Oral)
- Carbidopa and levodopa enteral
- Carbidopa, entacapone, and levodopa
- Dhivy
- Duopa
- Entacapone
- Gocovri
- Inbrija
- Kynmobi
- Levodopa
- Levodopa (Oral)
- Lodosyn
- Mirapex
- Mirapex ER
- Neupro
- Ongentys
- Opicapone
- Osmolex ER
- Parcopa
- Pramipexole
- Rasagiline
- Requip
- Requip XL
- Ropinirole
- Rotigotine
- Rotigotine transdermal
- Rytary
- Safinamide
- Sinemet
- Sinemet 10-100
- Sinemet 25-100
- Sinemet 25-250
- Sinemet CR
- Stalevo 100
- Stalevo 125
- Stalevo 150
- Stalevo 200
- Stalevo 50
- Stalevo 75
- Tasmar
- Tolcapone
- Xadago
How to use Inbrija
Usual Adult Dose for Parkinson's Disease:
84 mg via oral inhalation as needed when OFF period starts to return; may dose up to 5 times a day Maximum dose per OFF period: 84 mg Maximum daily dose: 420 mg Comments: -Therapy should be taken when symptoms of an OFF period start to return. -This drug has shown efficacy only in combination with levodopa/carbidopa therapy. -Oral inhalation capsules should only be used with the Inbrija(R) inhaler; capsules should not be swallowed whole as the intended effect will not be obtained. Use: For the intermittent treatment of OFF episodes in patients with Parkinson's disease treated with carbidopa/levodopa.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Inbrija
Using Inbrija with other drugs that make you drowsy can worsen this effect. Ask your doctor before using opioid medication, a sleeping pill, a muscle relaxer, or medicine for anxiety or seizures.
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with levodopa, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions